Cannabinoid Receptor
Cannabinoid Receptor
Cannabinoid receptors are currently classified into three groups: central (CB1), peripheral (CB2) and GPR55, all of which are G-protein-coupled. CB1 receptors are primarily located at central and peripheral nerve terminals. CB2 receptors are predominantly expressed in non-neuronal tissues, particularly immune cells, where they modulate cytokine release and cell migration. Recent reports have suggested that CB2 receptors may also be expressed in the CNS. GPR55 receptors are non-CB1/CB2 receptors that exhibit affinity for endogenous, plant and synthetic cannabinoids. Endogenous ligands for cannabinoid receptors have been discovered, including anandamide and 2-arachidonylglycerol.
Cannabinoid Receptor Isoform Specific Products
All Product Categories
-
Cannabinoid Receptor Inhibitors
(37)
View all products
-
Cannabinoid Receptor Agonists
(141)
View all products
-
Cannabinoid Receptor Antagonists
(76)
View all products
-
Cannabinoid Receptor Activators
(14)
View all products
-
Cannabinoid Receptor Modulators
(24)
View all products
-
Cannabinoid Receptor Chemical
(1)
View all products
-
Cannabinoid Receptor Inducer
(1)
View all products
-
Cannabinoid Receptor Degrader
(1)
View all products
-
Cannabinoid Receptor Controls
(2)
View all products
-
Cannabinoid Receptor Ligands
(13)
View all products
-
Cannabinoid Receptor Related Products (448)
Related Products (448)
-
Antibodies (1)
-
Cannabinoid Receptor Isoform Comparison
-
11-Hydroxy-9(S)-hexahydrocannabinol
0 ImagesCat. No.: HY-168795CAS No.: 74523-47-011-Hydroxy-9(S)-hexahydrocannabinol is a phytocannabinoid metabolite.
-
SAD448
0 ImagesCat. No.: HY-108067CAS No.: 581106-09-4
-
Delta8-THC acetate
0 ImagesCat. No.: HY-W775346CAS No.: 23050-54-6Synonyms: Δ8-THC acetate; Delta8-tetrahydrocannabinolDelta8-THC acetate (Delta8-tetrahydrocannabinol) is a psychoactive phytocannabinoid, that binds to cannabinoid receptor 1 (CB1 receptor), and exhibits anti-nausea, appetite-stimulating, and anti-inflammatory activities. Delta8-THC acetate exhibits probably neuroprotective efficacy and can be used in anti-anxiety and antidepressant research.
-
ARN272 (Standard)
0 ImagesCat. No.: HY-110101RCAS No.: 488793-85-7
-
CH-FUBIATA
0 ImagesCat. No.: HY-170720CAS No.: 922038-77-5CH-FUBIATA is structurally similar to known synthetic cannabinoids.
-
Bzo-poxizid-d9
0 ImagesCat. No.: HY-W783639SSynonyms: 5C-MDA-19-d9, Petyl MDA-19-d9Bzo-poxizid-d9 (5C-MDA-19-d9, Petyl MDA-19-d9) is deuterium labeled Bzo-poxizid. Bzo-poxizid is a synthetic cannabinoid that is a psychoactive substance.
-
2-(2-Chlorophenyl)-1-(1H-indol-3-yl)ethanone
0 ImagesCat. No.: HY-158814CAS No.: 1096914-22-52-(2-Chlorophenyl)-1-(1H-indol-3-yl)ethanone is a precursor in the synthesis of synthetic cannabinoids.
-
(±)-Cannabichromebutolic acid
0 ImagesCat. No.: HY-170744CAS No.: 2691096-32-7(±)-Cannabichromebutolic acid is structurally similar to known phytocannabinoids.
-
Cannabigerovarinic acid
0 ImagesCat. No.: HY-122799CAS No.: 64924-07-8Cannabigerovarinic acid is a cannabinoid acid, which is found in Thai Cannabis.
-
(±)-9-Nor-9α-hydroxy Hexahydrocannabinol
0 ImagesCat. No.: HY-168792CAS No.: 56469-26-2(±)-9-Nor-9α-hydroxy Hexahydrocannabinol is a cannabinoid-type compound that has strong cannabinoid-like activity in both dogs and mice.
-
5'-Hydroxy-9(R)-hexahydrocannabinol
0 ImagesCat. No.: HY-170042ACAS No.: 127367-74-25'-Hydroxy-9(R)-hexahydrocannabinol is a phytocannabinoid metabolite.
-
2-Fluoro QMPSB
0 ImagesCat. No.: HY-158943CAS No.: 2707165-48-6Synonyms: QMDFPSB; SGT-132-Fluoro QMPSB (QMDFPSB) is structurally similar to known synthetic cannabinoids.
-
CHO-4′Me-5′Br-FUBOXPYRA
0 ImagesCat. No.: HY-176077CAS No.: 3078516-17-0Synonyms: CH-FUBBMPDORACHO-4’Me-5’Br-FUBOXPYRA (CH-FUBBMPDORA) is an oxopyridine carboxamide that shares a similar structure to known synthetic cannabinoids. CHO-4’Me-5’Br-FUBOXPYRA demonstrates limited activation potential at both cannabinoid receptors CB1 and CB2.
-
(±)-9α-Hydroxy hexahydrocannabinol
0 ImagesCat. No.: HY-170045CAS No.: 16964-49-1Synonyms: (±)-9α-Hydroxy HHC; (±)-9α-OH-HHC(±)-9α-Hydroxy hexahydrocannabinol ((±)-9α-Hydroxy HHC) is structurally similar to known phytocannabinoids.
-
PF-03550096
0 ImagesCat. No.: HY-129787CAS No.: 910376-39-5PF-03550096 is an orally active synthetic cannabinoid (CB) that selectively targets peripheral CB2 receptors with a Ki value of 7.9 nM. PF-03550096 has analgesic activity.
-
MDMB-FUBICA metabolite 3
0 ImagesCat. No.: HY-172073CAS No.: 2693397-46-3MDMB-FUBICA metabolite 3 is structurally classified as a synthetic cannabinoid. MDMB-FUBICA metabolite 3 is a metabolite of MDMB-FUBICA.
-
Afubiata
0 ImagesCat. No.: HY-170666CAS No.: 2985275-14-5Afubiata is structurally similar to known synthetic cannabinoids.
-
Linderane (Standard)
0 ImagesCat. No.: HY-N0688RCAS No.: 13476-25-0Linderane (Standard) is the analytical standard of Linderane (HY-N0688). This product is intended for research and analytical applications. Linderane is an orally active natural sesquiterpene lactone with blood-brain barrier permeability. Linderane indirectly activates PDE3 by activating ERK/STAT3, thereby inhibiting the cAMP/PKA/CREB signaling pathway and hepatic gluconeogenesis. Linderane protects pancreatic β cells against oxidative damage by inhibiting the activation of the p38 MAPK pathway and activating the Nrf2 pathway. Linderane inhibits cell apoptosis and ameliorates intestinal mucosal inflammation by suppressing the IL-6/JAK/STAT3 signaling pathway. Linderane reduces pain sensitivity and alleviates anxiety-like behaviors by activating cannabinoid receptor 2 (CB2R). Linderane can be used in studies related to type 2 diabetes, ulcerative colitis, and chronic inflammatory pain with anxiety.
-
8(S)-Hydroxy-9(R)-hexahydrocannabinol
0 ImagesCat. No.: HY-168788CAS No.: 74509-39-08(S)-Hydroxy-9(R)-hexahydrocannabinol is structurally similar to known phytocannabinoids.
